427 related articles for article (PubMed ID: 28621619)
1. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.
Kim D; Niemierko A; Hwang WL; Stemmer-Rachamimov AO; Curry WT; Barker FG; Martuza RL; Oh KS; Loeffler JS; Shih HA
J Neurosurg; 2018 Apr; 128(4):1123-1132. PubMed ID: 28621619
[TBL] [Abstract][Full Text] [Related]
2. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes.
Marciscano AE; Stemmer-Rachamimov AO; Niemierko A; Larvie M; Curry WT; Barker FG; Martuza RL; McGuone D; Oh KS; Loeffler JS; Shih HA
J Neurosurg; 2016 Jan; 124(1):106-14. PubMed ID: 26274991
[TBL] [Abstract][Full Text] [Related]
3. A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas.
McGovern SL; Aldape KD; Munsell MF; Mahajan A; DeMonte F; Woo SY
J Neurosurg; 2010 May; 112(5):925-33. PubMed ID: 19799498
[TBL] [Abstract][Full Text] [Related]
4. Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma.
Park S; Cha YJ; Suh SH; Lee IJ; Lee KS; Hong CK; Kim JW
J Cancer Res Clin Oncol; 2019 May; 145(5):1351-1360. PubMed ID: 30953136
[TBL] [Abstract][Full Text] [Related]
5. Treatment Response and Prognosis After Recurrence of Atypical Meningiomas.
Cao X; Hao S; Wu Z; Wang L; Jia G; Zhang L; Zhang J
World Neurosurg; 2015 Oct; 84(4):1014-9. PubMed ID: 26038336
[TBL] [Abstract][Full Text] [Related]
6. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
7. Histopathological features to define atypical meningioma: What does really matter for prognosis?
Barresi V; Lionti S; Caliri S; Caffo M
Brain Tumor Pathol; 2018 Jul; 35(3):168-180. PubMed ID: 29671247
[TBL] [Abstract][Full Text] [Related]
8. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
[TBL] [Abstract][Full Text] [Related]
9. Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis.
Lamba N; Hwang WL; Kim DW; Niemierko A; Marciscano AE; Mehan WA; Benayoun MD; Curry WT; Barker FG; Martuza RL; Dunn IF; Claus E; Bi WL; Aizer AA; Alexander BM; Oh KS; Loeffler JS; Shih HA
World Neurosurg; 2020 Jan; 133():e804-e812. PubMed ID: 31605839
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
[TBL] [Abstract][Full Text] [Related]
11. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
[TBL] [Abstract][Full Text] [Related]
12. Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases.
Cornelius JF; Slotty PJ; Steiger HJ; Hänggi D; Polivka M; George B
Acta Neurochir (Wien); 2013 Mar; 155(3):407-13. PubMed ID: 23318687
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
14. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.
Oya S; Kawai K; Nakatomi H; Saito N
J Neurosurg; 2012 Jul; 117(1):121-8. PubMed ID: 22559847
[TBL] [Abstract][Full Text] [Related]
15. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma.
Maiuri F; Mariniello G; Guadagno E; Barbato M; Corvino S; Del Basso De Caro M
Acta Neurochir (Wien); 2019 Dec; 161(12):2553-2561. PubMed ID: 31637512
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
Bruna J; Brell M; Ferrer I; Gimenez-Bonafe P; Tortosa A
Neuropathology; 2007 Apr; 27(2):114-20. PubMed ID: 17494511
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in anterior skull base meningiomas.
Ciocan LM; Dănăilă L; Stănculescu DE; Neamţu SD; Mateescu GO; Stanca L
Rom J Morphol Embryol; 2014; 55(3 Suppl):1063-9. PubMed ID: 25607386
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Clinical Outcomes of Pencil Beam Scanning Proton Therapy for Benign and Non-benign Intracranial Meningiomas.
Murray FR; Snider JW; Bolsi A; Lomax AJ; Walser M; Kliebsch U; Schneider RA; Weber DC
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1190-1198. PubMed ID: 28939227
[TBL] [Abstract][Full Text] [Related]
19. Multimodal treatment of parasagittal meningiomas: a single-center experience.
Gatterbauer B; Gevsek S; Höftberger R; Lütgendorf-Caucig C; Ertl A; Mallouhi A; Kitz K; Knosp E; Frischer JM
J Neurosurg; 2017 Dec; 127(6):1249-1256. PubMed ID: 28156245
[TBL] [Abstract][Full Text] [Related]
20. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
